Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

astrazeneca_building_white

AstraZeneca scores second accelerated FDA review in 2 days for blood cancer drug

August 1, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, acalabrutinib, biotech, drugs, life sciences, pharma, pharmaceutical

It’s been a rollercoaster week for AstraZeneca.

News
astrazeneca_building_white

AZ’s Imfinzi scores FDA breakthrough therapy designation in wake of major trial failure

July 31, 2017
Sales and Marketing AstraZeneca, Imfinzi, drugs, healthcare, mystic, phaarmaceutical, pharma

Still reeling from the public reaction to the flop of its key Mystic trial, where its injectable immunotherapy drug Imfinzi …

News

AZ attempts to clear dust of Mystic trial with $8.5 billion MSD deal

July 27, 2017
Medical Communications, Sales and Marketing AstraZeneca, MSD, Merck, biotech, drugs, immunotherapy, mystic, pharma, pharmaceutical

It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …

News
astrazeneca-sign

AZ’s ‘blockbuster’ lung cancer drug fails, Q2 revenue falls

July 27, 2017
Research and Development, Sales and Marketing AstraZeneca, biotech, drugs, healthcare, pharma, pharmaceutical

The long-awaited results for AstraZeneca’s Mystic trial have been revealed and, in a shocking setback for the company, it was …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 21, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …

News
pascal_soriot

AstraZeneca’s Soriot Teva switch scotched

July 17, 2017
Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical

The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …

News
pascal_soriot

AstraZeneca’s CEO set for shock switch to Teva

July 13, 2017
Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical

It is no secret that Teva has been on the lookout for a new CEO and they had already been …

News
gagan_singh

AstraZeneca appoint new MD for India

July 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India

AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …

Appointment
astrazeneca_building_white

AstraZeneca generates $600 million from just two drug sales

July 3, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, Seloken, Zomig

AstraZeneca is expected to generate almost $600 million from just two drug sales: Zoming, a migraine therapy, and Seloken, a …

News
gsk_boronia_australia

GSK signs $43 million AI-based drug discovery deal with Exscientia

July 3, 2017
Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK

With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …

News
astrazeneca_sign_sky

New Pfizer EU approval offers first treatment option for leukaemia subtype

July 3, 2017
Sales and Marketing AstraZeneca, Besponsa, EU, European Commission

Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy for …

News

NICE recommends AstraZeneca lung treatment

July 3, 2017
Sales and Marketing AstraZeneca, Daxas, NICE

AstraZeneca’s Daxas (roflumilast) has received recommendation from NICE for the treatment of chronic obstructive pulmonary disease (COPD) it has emerged, …

News
gsk_boronia_australia

GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit

June 20, 2017
Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels

The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …

News
astrazeneca_sign_sky

AZ withdraws Brilinta batch for containing the wrong drug after packaging mix-up

June 6, 2017
Manufacturing and Production AstraZeneca

The United Arab Emirates Ministry of Health and Prevention has called for the withdrawal of a batch of AstraZeneca’s cardiovascular …

News
astrazeneca_sign_sky

AZ’s Lynparza improves survival and maintains quality of life against ovarian cancer

June 2, 2017
Medical Communications, Research and Development AstraZeneca, lynparza

New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025